BMCS Stock Overview
BioTech Medics, Inc. operates as a medical-based holding company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioTech Medics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.024 |
| 52 Week High | US$0.049 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 20.00% |
| 3 Month Change | 6.67% |
| 1 Year Change | 370.59% |
| 3 Year Change | -60.07% |
| 5 Year Change | 1,137.11% |
| Change since IPO | -99.89% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BMCS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | -3.7% |
| 1Y | 370.6% | 0.8% | 20.5% |
Return vs Industry: BMCS exceeded the US Healthcare industry which returned -2.9% over the past year.
Return vs Market: BMCS exceeded the US Market which returned 20.2% over the past year.
Price Volatility
| BMCS volatility | |
|---|---|
| BMCS Average Weekly Movement | 29.2% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BMCS's share price has been volatile over the past 3 months.
Volatility Over Time: BMCS's weekly volatility has decreased from 69% to 29% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Tom Miller | biotecmedics.com |
BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer.
BioTech Medics, Inc. Fundamentals Summary
| BMCS fundamental statistics | |
|---|---|
| Market cap | US$4.78m |
| Earnings (TTM) | -US$603.72k |
| Revenue (TTM) | US$469.80k |
0.0x
P/S Ratio0.0x
P/E RatioIs BMCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMCS income statement (TTM) | |
|---|---|
| Revenue | US$469.80k |
| Cost of Revenue | US$61.66k |
| Gross Profit | US$408.14k |
| Other Expenses | US$1.01m |
| Earnings | -US$603.72k |
Last Reported Earnings
Dec 31, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BMCS perform over the long term?
See historical performance and comparison